Selective induction of apoptosis: promising therapy in pancreatic cancer.
about
Activator protein 1 promotes gemcitabine‑induced apoptosis in pancreatic cancer by upregulating its downstream target BimSmall Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK SignalingActivation of proteinase-activated receptor 2 prevents apoptosis of lung cancer cells.Mitochondrial Changes in Cancer.Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer.
P2860
Selective induction of apoptosis: promising therapy in pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Selective induction of apoptosis: promising therapy in pancreatic cancer.
@en
type
label
Selective induction of apoptosis: promising therapy in pancreatic cancer.
@en
prefLabel
Selective induction of apoptosis: promising therapy in pancreatic cancer.
@en
P2093
P1476
Selective induction of apoptosis: promising therapy in pancreatic cancer.
@en
P2093
P304
P356
10.2174/1381612811319120013
P577
2013-01-01T00:00:00Z